当前位置: X-MOL 学术Thorac. Cancer › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Chinese expert consensus on the diagnosis and treatment of thymic epithelial tumors
Thoracic Cancer ( IF 2.3 ) Pub Date : 2023-03-16 , DOI: 10.1111/1759-7714.14847
Chunwei Xu 1, 2, 3 , Yongchang Zhang 4 , Wenxian Wang 2 , Qian Wang 5 , Ziming Li 6 , Zhengbo Song 2 , Jiandong Wang 7 , Jinpu Yu 8 , Jingjing Liu 9 , Shirong Zhang 10 , Xiuyu Cai 11 , Ming Wu 12 , Ping Zhan 3 , Hongbing Liu 3 , Tangfeng Lv 3 , Liyun Miao 13 , Lingfeng Min 14 , Jiancheng Li 15 , Baogang Liu 16 , Jingping Yuan 17 , Zhansheng Jiang 18 , Gen Lin 19 , Xiaohui Chen 20 , Xingxiang Pu 21 , Chuangzhou Rao 22 , Dongqing Lv 23 , Zongyang Yu 24 , Xiaoyan Li 25 , Chuanhao Tang 26 , Chengzhi Zhou 27 , Junping Zhang 28 , Hui Guo 29 , Qian Chu 30 , Rui Meng 31 , Xuewen Liu 32 , Jingxun Wu 33 , Xiao Hu 34 , Min Fang 34 , Jin Zhou 35 , Zhengfei Zhu 36 , Xiaofeng Chen 37 , Weiwei Pan 38 , Fei Pang 39 , Yuxiang Zhou 39 , Qijie Jian 39 , Kai Wang 39 , Liping Wang 40 , Youcai Zhu 41 , Guocai Yang 42 , Xinqing Lin 27 , Jing Cai 43 , Lijun Liang 12 , Huijing Feng 28 , Lin Wang 44 , Yingying Du 45 , Wang Yao 46 , Xuefei Shi 47 , Xiaomin Niu 6 , Dongmei Yuan 3 , Yanwen Yao 3 , Jianhui Huang 48 , Yinbin Zhang 49 , Pingli Sun 50 , Hong Wang 51 , Mingxiang Ye 3 , Dong Wang 3 , Zhaofeng Wang 3 , Yue Hao 2 , Zhen Wang 52 , Bing Wan 53 , Donglai Lv 54 , Genhua Yu 55 , Anna Li 56 , Jin Kang 56 , Jiatao Zhang 56 , Chao Zhang 56 , Huafei Chen 41 , Lin Shi 57 , Leiguang Ye 16 , Gaoming Wang 58 , Yina Wang 59 , Feng Gao 60 , Wei Zhou 1 , Chunxiu Hu 61 , Jianguo Wei 62 , Bihui Li 63 , Zhongwu Li 64 , Yuan Li 65 , Zhefeng Liu 51 , Nong Yang 3 , Lin Wu 21 , Qiming Wang 66 , Wenbin Huang 67 , Zhuan Hong 68 , Guansong Wang 69 , Meiyu Fang 4 , Yong Fang 70 , Xixu Zhu 52 , Kaiqi Du 41 , Jiansong Ji 71 , Yi Shen 72 , Yiping Zhang 4 , Shenglin Ma 73 , Yong Song 3 , Yuanzhi Lu 74 , Anwen Liu 43 , Wenfeng Fang 75 , Wenzhao Zhong 56
Affiliation  

Thymic epithelial tumors (TETs) are a relatively rare type of thoracic tumor, accounting for less than 1% of all tumors. The incidence of TETs is about 3.93/10000 in China, slightly higher than that of European and American countries. For resectable TETs, complete surgical resection is recommended. Radiotherapy or chemotherapy may be used as postoperative adjuvant treatment. Treatment for advanced, unresectable TETs consist mainly of radiotherapy and chemotherapy, but there is a lack of standard first- and second-line treatment regimens. Recently, targeted therapies and immune checkpoint inhibitors have shown promising outcomes in TETs. Based on the currently available clinical evidences and the opinions of the national experts, the Thymic Oncology Group of Yangtze River Delta Lung Cancer Cooperation Group (East China LUng caNcer Group, ECLUNG; Youth Committee) established this Chinese expert consensus on the clinical diagnosis and treatment of TETs, covering the epidemiology, diagnosis, treatment, prognosis and follow-up of TETs.
更新日期:2023-03-16
down
wechat
bug